Abstract:Background: Runt-related transcription factor 3 (RUNX3) is a novel tumor suppressor gene that is frequently silenced by promoter hypermethylation in gastric cancer. In this study, we aimed to analyze the methylation status of the RUNX3 promoter in breast cancer and to evaluate the relationship between RUNX3 expression and breast carcinogenesis and prognosis. Methods: RT-PCR and Western blot were applied on 5 breast cancer cell lines, the human normal breast cell line Hs578Bst and 30 pairs of breast cancer and their matching normal breast tissues to detect mRNA and protein expression of the RUNX3 gene. Methylation-specific PCR was employed to detect the methylation status of the RUNX3 promoter. Immunohistochemical study was performed to analyze RUNX3 protein expression in 88 breast cancer tissues and 40 breast fibroadenomas. Results: The expression of RUNX3 mRNA and protein were negative in 3 breast cancer cell lines (T47D, MCF7 and SKBR3) as analyzed by RT-PCR and Western blotting. Hypermethylation of the RUNX3 promotor was identified in the T47D and MCF7 cell lines, but was not detected in SKBR3. Western blot analysis showed that the RUNX3 protein of 44 kDa was detected in 15 of 30 (50%) breast cancers. However, RUNX3 protein was detected in all normal breast tissues. Methylation was detected in 13 of the 15 tissues (86.67%) that did not express RUNX3 protein, but was never detected in any surrounding normal tissues. Immunohistochemistry results revealed that the positive rate of RUNX3 protein expression in breast cancer (35.23%) was much lower than that in breast fibroadenoma (85%). RUNX3 expression was correlated with tumor infiltration, clinical stage, lymph node metastasis and the expression of estrogen and progesterone receptor (p < 0.05), but was not related to age, tumor types and pathological grade (p < 0.05). The survival rate of the patients with RUNX3-positive expression was higher than that with RUNX3-negative expression (p < 0.05). Conclusions: The expression of RUNX3 gene is decreased in breast cancer. The RUNX3 gene may play an important role in the carcinogenesis of breast cancer. The mechanism of its inactivation may be hypermethylation of the promoter. With the increased progression of breast cancer, the expression of RUNX3 protein tends to decrease. The expression of RUNX3 protein has a definite value in judging prognosis in breast cancer. Copyright (c) 2008 S. Karger AG, Basel.

RUNX3 Gene Promoter Demethylation by 5-Aza-cdr Induces Apoptosis in Breast Cancer MCF-7 Cell Line

Effect of 5-Aza-2′-deoxycytidine in High-Risk Myelodysplasia Cells in Vitro.

Effect of 5-Aza-cdr on RUNX3 Expression and the Proliferation of Human Hepatocarcinoma Cell Line HepG2

RUNX3 gene methylation in a cutaneous malignant melanoma cell line A375

Preliminary study of expression and modulating factors of runt-related transcription factor 3 and their methylation in human gastric cancer cell lines

Effect of 5-Aza-cdr on Cell Proliferation and Apoptosis in Ovarian Cancer Cell Line and Expression of Tumor Suppressor Gene RUNX3

RUNX3 is Involved in Caspase-3-dependent Apoptosis Induced by a Combination of 5-Aza-cdr and TSA in Leukaemia Cell Lines

Effects of 5-azacytidine on RUNX3 gene expression and the biological behavior of esophageal carcinoma cells.

RUNX3 gene methylation in ovarian cancer cell lines

Effect of Hydralazine on Methylation and Expression of RUNX3 Gene in Human Gastric Cancer Cell Lines

Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.

Role of 5-Aza-2'-deoxycytidine in Breast Cancer Cells CDH4 Promoter Demethylation

Alteration of Runt-related Transcription Factor 3 Gene Expression and Biologic Behavior of Esophageal Carcinoma TE-1 Cells after 5-Azacytidine Intervention

Hypermethylation Downregulates Runx3 Gene Expression and Its Restoration Suppresses Gastric Epithelial Cell Growth by Inducing P27 and Caspase3 in Human Gastric Cancer

Analysis of the status of Runx3 gene promoter methylation in breast cancer and its relationship with pathological features

Study the expression and methylation of Runx3 gene promoter region in colorectal cancer tumor tissues

Runx3 Is Frequently Inactivated By Dual Mechanisms Of Protein Mislocalization And Promoter Hypermethylation In Breast Cancer

Methyltransferase 3A-Mediated Promoter Methylation Represses Retinoic Acid Receptor Responder 3 Expression in Basal-Like Breast Cancer

Promoter Hypermethylation of Runx3 Gene in Gastric Cancer and its Clinical Significance

Effect of DR4 Promoter Methylation on the TRAIL-induced Apoptosis in Lung Squamous Carcinoma Cell.

[Methylation of Runx3 Promoter in Different Breast Lesions].